Skip to main content
. 2016 Feb 16;2016(2):CD009310. doi: 10.1002/14651858.CD009310.pub2
Study Reason for exclusion
Bernasconi 1998 Less than 80% MDS patients
Bowen 2004 EPO and G‐CSF versus placebo
Bowen 2006 EPO and G‐CSF versus placebo
Estey 1999 Less than 80% MDS patients
Gerhartz 1994 GM‐CSF in both arms
Gotlib 2009 Not randomised
Greenberg 2009 G‐CSF not randomised
Hast 2003 Not MDS
Miller 1998 Editorial
Schuster 1989 Cross‐over design and abstract publication. Unclear, how many patients crossed‐over, no results before crossing over
Schuster 1995 Cross‐over design and abstract publication. No results for each arm of the entire group published
Stasi 2004 Editorial
Terpos 2000 Not randomised
Thompson 1995 GM‐CSF in both arms
Willemze 1992 Editorial

EPO: erythropoietin
 G‐CSF: granulocyte colony stimulating factors
 MDS: myelodysplastic syndromes